bc8b00190_si_001.pdf (1.27 MB)
Download fileAntifibrotic Effect of Ketoprofen-Grafted Alginate Microcapsules in the Transplantation of Insulin Producing Cells
journal contribution
posted on 2018-05-22, 00:00 authored by François Noverraz, Elisa Montanari, Joël Pimenta, Luca Szabó, Daniel Ortiz, Carmen Gonelle-Gispert, Léo H. Bühler, Sandrine Gerber-LemaireThe controlled release of small molecular
modulators of the immune
response from hydrogel microspheres (MS) used for cell immobilization
is an attractive approach to reduce pericapsular fibrotic overgrowth
(PFO) after transplantation. Ketoprofen is a well-known nonsteroidal
anti-inflammatory drug involved in the early stage inflammation cascade.
PEGylated derivatives of ketoprofen, presenting either ester or amide
linkage to the drug, were synthesized and conjugated to the hydroxyl
groups of sodium alginate (Na-alg). Functionalized cell-free and MIN6
cells containing MS were produced from the resulting modified alginates.
In vitro quantification of ketoprofen release indicated regular and
sustained drug delivery over 14 days, resulting from the hydrolytic
cleavage of the ester bond. The release kinetics was enhanced over
the initial 7 days by the presence of MIN6 cells, probably as a result
of cell esterase activity. In the presence of amide bond, traces of
ketoprofen were released over 14 days due to a much slower hydrolysis
kinetics. Cell-free and MIN6 cells containing MS were transplanted
in immune-competent mice, either in the peritoneal cavity or under
the kidney capsule, with a follow-up period of 30 days. Comparison
with nonmodified Ca-alg MS transplanted in the same conditions demonstrated
a clear reduction in the severity of PFO for MS functionalized with
ketoprofen. Quantification of collagen deposition on MIN6 cells containing
MS transplanted under the kidney capsule revealed the significant
effect of ketoprofen release to decrease fibrotic tissue formation.
The impact was more pronounced when the drug was covalently conjugated
by an ester linkage, allowing higher concentration of the anti-inflammatory
compound to be delivered at the transplantation site. The functionality
of microencapsulated MIN6 cells 30 days after transplantation was
confirmed by detection of insulin positive cell content.
History
Usage metrics
Read the peer-reviewed publication
Categories
Keywords
nonmodified Ca-alg MSmicroencapsulated MIN 6 cells 30 dayspericapsular fibrotic overgrowthKetoprofen-Grafted Alginate MicrocapsulestransplantationMIN 6 cellsdecrease fibrotic tissue formationnonsteroidal anti-inflammatory drugketoprofen releasestage inflammation cascadekidney capsule14 daysInsulin Producing Cellscell esterase activityPFO